Review of 2009: Tissue engineering and advanced cellular therapies emerge as next-gen biotech
This article was originally published in Clinica
Executive Summary
Despite the extensive research into stem cells, the biotech industry has hitherto been unable to capitalise on the vast therapeutic potential of these technologies. Now they are being surpassed by more advanced forms of genetic manipulation whereby human genes, cells, and even entire tissues, can be engineered to address disorders including wounds, vascular malfunction and infections. This could be the future of biotechnology, writes Elizabeth Cairns